HBM4EU chromates study - PFAS exposure in electroplaters and bystanders.

Bystanders Human biomonitoring Occupational exposure Perfluoroalkyl substances Persistent substances

Journal

Chemosphere
ISSN: 1879-1298
Titre abrégé: Chemosphere
Pays: England
ID NLM: 0320657

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 13 07 2023
revised: 31 10 2023
accepted: 01 11 2023
medline: 27 11 2023
pubmed: 10 11 2023
entrez: 9 11 2023
Statut: ppublish

Résumé

The study aims to reveal the exposure to perfluoroalkyl substances (PFAS) in workers in different industry sectors with exposures to hexavalent chromium (Cr(VI)). The PFAS exposure of in total 172 individuals from 4 countries was assessed by the determination of 8 perfluoroalkyl carboxylic acids and 4 perfluoroalkyl sulfonic acids in plasma samples. The participants were 52 chrome plating workers, 43 welders, 3 surface treating workers and 74 workers without any occupational Cr exposure as controls. Significant differences between workers with Cr exposure and controls were found for the perfluoroalkyl sulfonic acids, particularly for perfluorooctane sulfonic acid (PFOS). The median and maximum levels were, respectively, 4.83 and 789 μg/l for chrome plating workers, 4.97 and 1513 μg/l for welders, and 3.65 and 13.9 μg/l for controls. The considerably high PFOS exposure in Cr platers and welders can be explained by the former application of PFOS as mist suppressants in electroplating baths, which resulted in an exposure of the directly involved operators, but also of welders performing maintenance and repair service at these workplaces.

Identifiants

pubmed: 37944767
pii: S0045-6535(23)02883-7
doi: 10.1016/j.chemosphere.2023.140613
pii:
doi:

Substances chimiques

Chromates 0
perfluorooctane sulfonic acid 9H2MAI21CL
Alkanesulfonic Acids 0
Sulfonic Acids 0
Fluorocarbons 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140613

Investigateurs

Katrien Poels (K)
Guillaume Antoine (G)
Mathieu Melczer (M)
Andrea Cattaneo (A)
Domenico M Cavallo (DM)
Giuseppe De Palma (G)
Angela Gambelunghe (A)
Piero Lovreglio (P)
Kukka Aimonen (K)
Riitta Velin (R)

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Thomas Göen (T)

Friedrich-Alexander-Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Erlangen, Germany. Electronic address: thomas.goeen@fau.de.

Annalisa Abballe (A)

Istituto Superiore di Sanità, Department of Environment and Health, Rome, Italy.

Radia Bousoumah (R)

French National Research and Safety Institute (INRS), Vandœuvre-Lès-Nancy, France.

Lode Godderis (L)

Catholic University Leuven, Centre for Environment and Health, Department of Public Health and Primary Care, Leuven, Belgium; IDEWE, External Service for Prevention and Protection at Work, Heverlee, Belgium.

Ivo Iavicoli (I)

University of Naples Federico II, Department of Public Health, Naples, Italy.

Anna Maria Ingelido (AM)

Istituto Superiore di Sanità, Department of Environment and Health, Rome, Italy.

Veruscka Leso (V)

University of Naples Federico II, Department of Public Health, Naples, Italy.

Johannes Müller (J)

Friedrich-Alexander-Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Erlangen, Germany.

Sophie Ndaw (S)

French National Research and Safety Institute (INRS), Vandœuvre-Lès-Nancy, France.

Simo P Porras (SP)

Finnish Institute of Occupational Health (FIOH), Helsinki, Finland.

Jelle Verdonck (J)

Catholic University Leuven, Centre for Environment and Health, Department of Public Health and Primary Care, Leuven, Belgium.

Tiina Santonen (T)

Finnish Institute of Occupational Health (FIOH), Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH